Is Scienture Holdings, Inc. (SCNX) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 21.9% / 30% | 1.9% / 30% | 33.9% / 30% | 99.04% / 5% | ✗ NOT HALAL |
| DJIM | 21.9% / 33% | 1.9% / 33% | 33.9% / 33% | 99.04% / 5% | ✗ NOT HALAL |
| MSCI | 3.4% / 33% | 0.3% / 33% | 5.2% / 33% | 99.04% / 5% | ✗ NOT HALAL |
| S&P | 21.9% / 33% | 1.9% / 33% | 33.9% / 33% | 99.04% / 5% | ✗ NOT HALAL |
| FTSE | 3.4% / 33% | 0.3% / 33% | 5.2% / 50% | 99.04% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 88.5% | |
| Operating Margin | -739.1% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -24.1% | |
| Return on Assets (ROA) | -10.9% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$14M |
| Free Cash Flow | -$14M |
| Total Debt | $4M |
| Debt-to-Equity | 3.1 |
| Current Ratio | 0.2 |
| Total Assets | $105M |
Price & Trading
| Last Close | $0.45 |
| 50-Day MA | $0.45 |
| 200-Day MA | $0.88 |
| Avg Volume | 3.4M |
|
52-Week Range
$0.37
| |
About Scienture Holdings, Inc. (SCNX)
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products. The Scienture segment researches and develops branded pharmaceutical products. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is based in Tampa, Florida.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Scienture Holdings, Inc. (SCNX) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Scienture Holdings, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Scienture Holdings, Inc.'s debt ratio?
Scienture Holdings, Inc.'s debt ratio is 21.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 3.4%.
What are Scienture Holdings, Inc.'s key financial metrics?
Scienture Holdings, Inc. has a market capitalization of $17M, trailing P/E ratio of 0.6, and revenue of $136,643. Return on equity stands at -24.1%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.